Interaction of hepatic stellate cells with diverse types of immune cells: Foe or friend?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue SUPPL 1, 2013, Pages 99-104

  Yi, Hyon Seung ^a   Jeong, Won II ^a,b  

^a Graduate School of Medical Science and Engineering   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Bone marrow cell; Interleukin 17; Macrophage; Natural killer cell; Regulatory T cell

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 27; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ALCOHOL LIVER DISEASE; ANTIGEN PRESENTING CELL; BONE MARROW; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; KUPFFER CELL; LIVER FIBROSIS; MACROPHAGE; NATURAL KILLER T CELL; NEUTROPHIL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STELLATE CELL;

EID: 84880406477     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12017     Document Type: Review

References (57)

1. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011; 6: 425-456.
2. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008; 88: 125-172.
3. Muhanna N, Doron S, Wald O etal. Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis. Hepatology 2008; 48: 963-977.
4. Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan D. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 2011; 53: 230-242.
5. Seki E, De Minicis S, Osterreicher CH etal. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007; 13: 1324-1332.
6. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: S54-62.
7. Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47: 729-736.
8. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol. Rev. 2000; 174: 5-20.
9. Crispe IN. The liver as a lymphoid organ. Annu. Rev. Immunol. 2009; 27: 147-163.
10. Bataller R, Brenner DA. Liver fibrosis. J. Clin. Invest. 2005; 115: 209-218.
11. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005; 128: 138-146.
12. Seki E, de Minicis S, Inokuchi S etal. CCR2 promotes hepatic fibrosis in mice. Hepatology 2009; 50: 185-197.
13. Casini A, Ceni E, Salzano R etal. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 1997; 25: 361-367.
14. Sprenger H, Kaufmann A, Garn H, Lahme B, Gemsa D, Gressner AM. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology 1997; 113: 277-285.
15. Maher JJ, Lozier JS, Scott MK. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am. J. Physiol. 1998; 275: G847-853.
16. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007; 25: 821-852.
17. Lemmers A, Moreno C, Gustot T etal. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-657.
18. Meng F, Wang K, Aoyama T etal. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012; 143: 765-776 e763.
19. Safadi R, Ohta M, Alvarez CE etal. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 2004; 127: 870-882.
20. Panasiuk A, Prokopowicz D, Zak J, Wysocka J. Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C. Hepatogastroenterology 2003; 50: 178-182.
21. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007; 13: 139-145.
22. Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J. Leukoc. Biol. 2009; 86: 513-528.
23. Jin Z, Sun R, Wei H, Gao X, Chen Y, Tian Z. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 2011; 53: 219-229.
24. Ishikawa S, Ikejima K, Yamagata H etal. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J. Hepatol. 2011; 54: 1195-1204.
25. Park O, Jeong WI, Wang L etal. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009; 49: 1683-1694.
26. Russo FP, Alison MR, Bigger BW etal. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006; 130: 1807-1821.
27. Forbes SJ, Russo FP, Rey V etal. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126: 955-963.
28. Kisseleva T, Uchinami H, Feirt N etal. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 2006; 45: 429-438.
29. Karlmark KR, Weiskirchen R, Zimmermann HW etal. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009; 50: 261-274.
30. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006; 130: 435-452.
31. Melhem A, Muhanna N, Bishara A etal. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J. Hepatol. 2006; 45: 60-71.
32. Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 2006; 44: 1441-1451.
33. Jeong WI, Park O, Suh YG etal. Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 2011; 53: 1342-1351.
34. Pockros PJ, Jeffers L, Afdhal N etal. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 2007; 45: 569-578.
35. Glassner A, Eisenhardt M, Kramer B etal. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab. Invest. 2012; 92: 967-977.
36. Kramer B, Korner C, Kebschull M etal. Natural killer p46(High) expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 2012; 56: 1201-1213.
37. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008; 134: 248-258.
38. Petersen BE, Bowen WC, Patrene KD etal. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-1170.
39. Sakaida I, Terai S, Yamamoto N etal. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004; 40: 1304-1311.
40. Terai S, Ishikawa T, Omori K etal. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292-2298.
41. Suh YG, Kim JK, Byun JS etal. CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology 2012; 56: 1902-1912.
42. Thomas JA, Pope C, Wojtacha D etal. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 2011; 53: 2003-2015.
43. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007; 7: 585-598.
44. Lan RY, Cheng C, Lian ZX etal. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006; 43: 729-737.
45. Sakaki M, Hiroishi K, Baba T etal. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol. Res. 2008; 38: 354-361.
46. Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H. Hepatic stellate cells function as regulatory bystanders. J. Immunol. 2011; 186: 5549-5555.
47. Chou HS, Hsieh CC, Yang HR etal. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 2011; 53: 1007-1019.
48. Dangi A, Sumpter TL, Kimura S etal. Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J. Immunol. 2012; 188: 3667-3677.
49. Kong X, Feng D, Wang H etal. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 2012; 56: 1150-1159.
50. Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 2011; 51: 267-288.
51. Manuelpillai U, Lourensz D, Vaghjiani V etal. Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis. PLoS One 2012; 7: e38631.
52. Fallowfield JA, Mizuno M, Kendall TJ etal. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 2007; 178: 5288-5295.
53. Connolly MK, Bedrosian AS, Mallen-St Clair J etal. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 2009; 119: 3213-3225.
54. Jiao J, Sastre D, Fiel MI etal. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology 2012; 55: 244-255.
55. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572-1585.
56. Jeong WI, Osei-Hyiaman D, Park O etal. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 2008; 7: 227-235.
57. Lee YS, Jeong WI. Retinoic acids and hepatic stellate cells in liver disease. J. Gastroenterol. Hepatol. 2012; 27 (Suppl. 2): 75-79.